Renaissance Group LLC Increases Holdings in Huron Consulting Group Inc. $HURN

Renaissance Group LLC increased its stake in Huron Consulting Group Inc. (NASDAQ:HURN) by 29.3% during the second quarter, according to its most recent filing with the SEC. The fund owned 65,214 shares of the business services provider’s stock after buying an additional 14,770 shares during the quarter. Renaissance Group LLC owned 0.38% of Huron Consulting Group worth $8,970,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in HURN. Savant Capital LLC raised its position in Huron Consulting Group by 6.9% in the second quarter. Savant Capital LLC now owns 1,686 shares of the business services provider’s stock worth $232,000 after acquiring an additional 109 shares during the period. CWM LLC increased its stake in shares of Huron Consulting Group by 55.9% during the 1st quarter. CWM LLC now owns 407 shares of the business services provider’s stock worth $58,000 after purchasing an additional 146 shares during the last quarter. Aigen Investment Management LP raised its holdings in shares of Huron Consulting Group by 10.5% in the 1st quarter. Aigen Investment Management LP now owns 1,879 shares of the business services provider’s stock worth $270,000 after purchasing an additional 178 shares during the period. Police & Firemen s Retirement System of New Jersey lifted its stake in Huron Consulting Group by 5.7% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 3,966 shares of the business services provider’s stock valued at $545,000 after purchasing an additional 215 shares during the last quarter. Finally, Quarry LP purchased a new stake in Huron Consulting Group in the first quarter worth $31,000. Hedge funds and other institutional investors own 93.90% of the company’s stock.

Insider Buying and Selling

In other news, Director James H. Roth sold 2,000 shares of Huron Consulting Group stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $164.13, for a total transaction of $328,260.00. Following the completion of the sale, the director owned 37,304 shares in the company, valued at approximately $6,122,705.52. This trade represents a 5.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director John Mccartney sold 500 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $164.24, for a total value of $82,120.00. Following the transaction, the director directly owned 49,817 shares of the company’s stock, valued at $8,181,944.08. The trade was a 0.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 17,808 shares of company stock worth $2,823,525. Corporate insiders own 2.15% of the company’s stock.

Huron Consulting Group Price Performance

HURN stock opened at $161.00 on Wednesday. The firm has a 50 day moving average of $152.37 and a 200-day moving average of $143.34. The firm has a market capitalization of $2.78 billion, a P/E ratio of 26.97 and a beta of 0.28. Huron Consulting Group Inc. has a 12 month low of $116.77 and a 12 month high of $174.26. The company has a current ratio of 1.44, a quick ratio of 1.99 and a debt-to-equity ratio of 1.18.

Huron Consulting Group (NASDAQ:HURN) last posted its earnings results on Tuesday, October 28th. The business services provider reported $2.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.24. The business had revenue of $441.28 million for the quarter, compared to analysts’ expectations of $418.13 million. Huron Consulting Group had a net margin of 6.54% and a return on equity of 27.06%. The business’s revenue for the quarter was up 16.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.68 EPS. Huron Consulting Group has set its FY 2025 guidance at 7.600-7.700 EPS. As a group, sell-side analysts predict that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on HURN. Barrington Research lifted their price objective on Huron Consulting Group from $173.00 to $176.00 and gave the stock an “outperform” rating in a report on Thursday, August 7th. Benchmark lifted their target price on shares of Huron Consulting Group from $165.00 to $180.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Wall Street Zen raised shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a research report on Saturday, November 1st. Weiss Ratings reiterated a “buy (b)” rating on shares of Huron Consulting Group in a research note on Wednesday, October 8th. Finally, Truist Financial boosted their target price on shares of Huron Consulting Group from $180.00 to $240.00 and gave the company a “buy” rating in a report on Friday, November 14th. Six equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Huron Consulting Group currently has a consensus rating of “Buy” and an average target price of $190.25.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.